HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance.

Abstract
Recent studies strongly support an association of the nicotinic acetylcholine receptor gene cluster CHRNA5-CHRNA3-CHRNB4 with nicotine dependence (ND). However, the precise genotype-phenotype relationship is still unknown. Clinical and epidemiological data on smoking behavior raise the possibility that the relevant gene variants may indirectly contribute to the development of ND by affecting cognitive performance in some smokers who consume nicotine for reasons of "cognition enhancement." Here, we tested seven single nucleotide polymorphisms (SNPs) rs684513, rs637137, rs16969968, rs578776, rs1051730, rs3743078, rs3813567 from the CHRNA5-CHRNA3-CHRNB4 gene cluster for association with ND, measures of cognitive performance and gene expression. As expected, we found all SNPs being associated with ND in three independent cohorts (KORA, NCOOP, ESTHER) comprising 5,561 individuals. In an overlapping sample of 2,186 subjects we found three SNPs (rs16969968, rs1051730, rs3743078) being associated with cognitive domains from the Wechsler-Adult-Intelligence Scale (WAIS-R)-most notably in the performance subtest "object assembly" and the verbal subtest "similarities." In a refined analysis of a subsample of 485 subjects, two of these three SNPs (rs16969968, rs1051730) were associated with n-back task performance/Continuous Performance Test. Furthermore, two CHRNA5 risk alleles (rs684513, rs637137) were associated with CHRNA5 mRNA expression levels in whole blood in a subgroup of 190 subjects. We here report for the first time an association of CHRNA5-CHRNA3-CHRNB4 gene variants with cognition possibly mediating in part risk for developing ND. The observed phenotype-genotype associations may depend on altered levels of gene expression. © 2010 Wiley-Liss, Inc.
AuthorsGeorg Winterer, Kirstin Mittelstrass, Ina Giegling, Claudia Lamina, Christoph Fehr, Hermann Brenner, Lutz P Breitling, Barbara Nitz, Elke Raum, Heiko Müller, Jürgen Gallinat, Andreas Gal, Katharina Heim, Holger Prokisch, Thomas Meitinger, Annette M Hartmann, Hans-Jürgen Möller, Christian Gieger, H-Erich Wichmann, Thomas Illig, Norbert Dahmen, Dan Rujescu
JournalAmerican journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics (Am J Med Genet B Neuropsychiatr Genet) Vol. 153B Issue 8 Pg. 1448-58 (Dec 05 2010) ISSN: 1552-485X [Electronic] United States
PMID20886544 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2010 Wiley-Liss, Inc.
Chemical References
  • CHRNA5 protein, human
  • CHRNB4 protein, human
  • Nerve Tissue Proteins
  • RNA, Messenger
  • Receptors, Nicotinic
  • nicotinic receptor subunit alpha3
Topics
  • Adult
  • Aged
  • Chromosomes, Human, Pair 15 (genetics)
  • Cognition
  • Female
  • Gene Expression
  • Gene Expression Profiling
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Genetic Variation
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Multigene Family
  • Nerve Tissue Proteins (genetics)
  • Polymorphism, Single Nucleotide
  • RNA, Messenger (blood, genetics)
  • Receptors, Nicotinic (genetics)
  • Risk
  • Tobacco Use Disorder (genetics)
  • Wechsler Scales

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: